HB3710sam002 103RD GENERAL ASSEMBLY

Sen. Mattie Hunter

Filed: 5/10/2023

10300HB3710sam002 LRB103 27320 LNS 61797 a

AMENDMENT TO HOUSE BILL 3710

AMENDMENT NO. ______. Amend House Bill 3710, AS AMENDED, by replacing everything after the enacting clause with the following:

"Section 1. Short title. This Act may be cited as the Alternative Protein Innovation Task Force Act.

Section 5. Definitions. As used in this Act:

"Alternative proteins" means proteins created from plant-based, fermented, cell-cultured inputs and processes to create foods that share sensory characteristics with conventional meat and dairy.

"Cultivated meat" means meat that is produced in a bioreactor from animal cells using a cell cultivation process.

"Fermented protein" means a protein that is made from traditional fermentation, biomass fermentation, or precision fermentation.

"Plant-based protein" means a protein that is produced directly from a plant.

Section 10. Alternative Protein Innovation Task Force. The Alternative Protein Innovation Task Force is established for the purposes of investigating and studying alternative proteins to identify and evaluate possible opportunities that the protein innovation and the alternative protein industry offer in the State. The Task Force shall study and draft a report on how the State may best support the growing alternative protein industry in the State. The Task Force shall: (i) examine the potential economic development benefits and job creation potential of the plant-based protein, cultivated meat, and fermented protein industries in the State; (ii) identify the environmental impacts of alternative proteins and their supply chains; (iii) examine if alternative proteins can strengthen the State's food resilience; (iv) assess how alternative proteins may affect individual health, public health, and food security in the State; and (v) identify ways the State may foster the growth of the emerging alternative protein industry, including by reviewing past and present efforts made to support the broader biotech and life science industries.

Section 15. Membership; appointments; meeting.

(a) The Alternative Protein Innovation Task Force shall consist of the following members:

(1) one member of the Senate, who shall be appointed by the President of the Senate and shall serve as co-chair of the Task Force;

(2) one member of the Senate, who shall be appointed by the Minority Leader of the Senate;

(3) one member of the House of Representatives, who shall be appointed by the Speaker of the House of Representatives and shall serve as co-chair of the Task Force;

(4) one member of the House of Representatives, who shall be appointed by the Minority Leader of the House of Representatives;

(5) the Secretary of Commerce and Economic Opportunity or the Secretary's designee;

(6) the Director of Agriculture or the Director's designee;

(7) 5 members who are appointed by the Director of Agriculture. Of the members appointed by the Director of Agriculture, 3 members shall be commercial producers of agricultural commodities, of which one member shall be from the largest statewide agricultural association; and 2 members shall be representatives from the University of Illinois College of Agricultural, Consumer and Environmental Sciences engaged in nutritional research; and

(8) 6 members who are appointed by the Governor. Of the members appointed by the Governor, 2 members shall be engaged in academic or scientific research on alternative protein development at a State college or university; one member shall be a representative of a nonprofit organization dedicated to the development and accessibility of alternative proteins; one member shall be a representative of the State's agricultural biotechnology industry; one member shall be the president of the Illinois Biotechnology Industry Organization or the organization's designee; and one member shall be a representative from a multinational food processing and manufacturing corporation headquartered in this State.

(b) Members of the Task Force shall not receive compensation for their services to the Task Force.

(c) All appointments shall be made not later than 30 days after the effective date of this Act.

(d) The co-chairs of the Task Force shall schedule no fewer than 4 meetings of the Task Force, including not less than one public hearing. The co-chairs shall convene the first meeting of the Task Force within 60 days after the effective date of this Act.

Section 20. Report. The Task Force shall submit a report of its findings and recommendations to the General Assembly no later than December 31, 2023.

Section 99. Effective date. This Act takes effect upon becoming law.".